Prof. Karen Avraham and Shahar Taiber
A new study at Tel Aviv University presents an innovative treatment for deafness, based on the delivery of genetic material into the cells of the inner ear. The genetic material ‘replaces’ the genetic defect and enables the cell to continue functioning normally.
The scientists were able to prevent the gradual deterioration of hearing in mice with a genetic mutation for deafness. They maintain that this novel therapy could lead to a breakthrough in treating children born with various mutations that eventually cause deafness.
The study was led by Prof. Karen Avraham and Shahar Taiber, a student in the combined MD-PhD track, from the Department of Human Molecular Genetics and Biochemistry at the Sackler Faculty of Medicine, and the Sagol School of Neuroscience, and Prof. Jeffrey Holt from Boston Children’s Hospital and Harvard Medical School. Additional contributors included Prof. David Sprinzak from the School of Neurobiology, Biochemistry
Researchers develop new gene therapy for deafness ANI | Updated: Dec 27, 2020 22:01 IST
Tel Aviv [Israel], December 27 (ANI): An innovative treatment for deafness, based on the delivery of genetic material into the cells of the inner ear, gas been developed by researchers from Tel Aviv University. The genetic material replaces the genetic defect and enables the cells to continue functioning normally.
The scientists were able to prevent the gradual deterioration of hearing in mice that had a genetic mutation for deafness. They maintain that this novel therapy could lead to a breakthrough in treating children born with various mutations that eventually cause deafness.
Study presents novel gene therapy for deafness
A new study from Tel Aviv University (TAU) presents an innovative treatment for deafness, based on the delivery of genetic material into the cells of the inner ear. The genetic material replaces the genetic defect and enables the cells to continue functioning normally.
The scientists were able to prevent the gradual deterioration of hearing in mice that had a genetic mutation for deafness. They maintain that this novel therapy could lead to a breakthrough in treating children born with various mutations that eventually cause deafness.
The study was led by Professor Karen Avraham of the Department of Human Molecular Genetics and Biochemistry at TAU s Sackler Faculty of Medicine and Sagol School of Neuroscience. The paper was published in
Dec 24, 2020
The innovative therapy replaces defective genes with healthy genes and may prevent deafness in children born with genetic mutations that cause hearing loss.
By TPS
Israeli scientists at Tel Aviv University have developed a gene therapy for deafness, a breakthrough that may help in the treatment of children with hearing loss.
The innovative therapy, replacing defective genes with healthy genes, may prevent deafness in children born with genetic mutations that cause hearing loss.
The scientists developed a treatment for genetic deafness caused by a specific mutation identified for the first time in Israeli families, and then in the United Kingdom and Turkey.
Scientists at Tel Aviv University Develop Gene Therapy for Deafness | The Jewish Press - JewishPress com | Hana Levi Julian | 9 Tevet 5781 – December 23, 2020 jewishpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jewishpress.com Daily Mail and Mail on Sunday newspapers.